Tobias Kiechle
Papers
1
Total Citations
66
H-Index
1
About
Dr. Tobias Kiechle is a leading figure in respiratory drug discovery, specializing in the development of advanced in vitro models of the human airway. His primary research focuses on miniaturizing and optimizing air-liquid interface (ALI) epithelial cultures to better mimic the human lung environment for preclinical testing. His most notable contribution is the creation of a miniaturized 96-Transwell ALI human small airway epithelial model, a breakthrough that addresses the critical challenge of limited cell availability from clinical samples. This system, detailed in his highly cited 2020 paper (66 citations), enables high-throughput screening of respiratory drugs and toxicological compounds using far fewer primary cells than traditional methods. By reducing the scale of these complex cultures without sacrificing physiological relevance, Dr. Kiechle’s work has significantly accelerated the pace of respiratory research, offering a more ethical and efficient platform for studying diseases like asthma, COPD, and cystic fibrosis. His innovations are widely recognized as essential tools for bridging the gap between basic cell biology and clinical application.
Research Focus
Key Achievements
Top Papers
- 1